VAXELIS
NDC 63361-243, diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine, injection, suspension, from MSP Vaccine Company.
- Product NDC
- 63361-243
- Status
- Listed
- Labeler
- MSP Vaccine Company
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- VACCINE
- Marketing category
- BLA
- Application
- BLA125563
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63361-243 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)15 [Lf]/.5mL
- CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)5 [Lf]/.5mL
- BORDETELLA PERTUSSIS TOXOID ANTIGEN (GLUTARALDEHYDE INACTIVATED)20 ug/.5mL
- BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)20 ug/.5mL
- BORDETELLA PERTUSSIS PERTACTIN ANTIGEN3 ug/.5mL
- BORDETELLA PERTUSSIS FIMBRIAE 2/3 ANTIGEN5 ug/.5mL
- POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)29 [D'ag'U]/.5mL
- POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)7 [D'ag'U]/.5mL
- POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)26 [D'ag'U]/.5mL
- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN10 ug/.5mL
- HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN3 ug/.5mL
Pharmacologic classes
Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Diphtheria Toxoid [CS]; Haemophilus Vaccines [CS]; Hepatitis B Vaccines [CS]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Bordetella Pertussis Vaccine [EPC]; Inactivated Clostridium Tetani Vaccine [EPC]; Inactivated Corynebacterium Diphtheriae Vaccine [EPC]; Inactivated Haemophilus Influenzae B Vaccine [EPC]; Inactivated Hepatitis B Virus Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Inactivated Poliovirus Vaccine [EPC]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Pertussis Vaccine [CS]; Poliovirus Vaccines [CS]; Poliovirus Vaccines [CS]; Poliovirus Vaccines [CS]; Tetanus Toxoid [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63361-243-15 | 63361024315 | 10 SYRINGE in 1 PACKAGE (63361-243-15) / .5 mL in 1 SYRINGE (63361-243-88) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63361-243 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63361-243 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63361-243. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.